Tazmust 1.125GM Injection
Marketer
DrMajesty Healthcare
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Tazmust 1.125GM Injection
Tazmust 1.125GM Injection combines two antibiotics to combat diverse bacterial infections by eliminating harmful microorganisms. Administration should always be by a qualified healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity and must be followed precisely. Always adhere to your doctor's prescribed regimen. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, inform your doctor of any antibiotic allergies, liver, or kidney impairments, as this may necessitate dosage adjustments or alternative medication. While generally safe during pregnancy and lactation under medical guidance, close monitoring is essential.
Uses of Tazmust 1.125GM Injection
Infections caused by bacteria
Major Benefits of Tazmust 1.125GM Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Tazmust 1.125GM Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazmust 1.125GM Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Tazmust 1.125GM Injection works:
Tazmust 1.125GM Injection merges Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance, optimizing Piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Tazmust 1.125GM Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazmust 1.125GM is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Tazmust 1.125GM Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazmust 1.125GM Injection on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Tazmust 1.125GM Injection with careful monitoring. Dosage modification of Tazmust 1.125GM Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazmust 1.125GM Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates that dosage modification may not be necessary for this patient population. Physician consultation is advised.
What if you forget to take Tazmust 1.125GM Injection :
Omit a scheduled Tazmust 1.125GM Injection? Seek medical advice immediately.
Facts to Know About Tazmust 1.125GM Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |

